An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts
P Bader, P McDonald, P Selby - Tobacco control, 2009 - tobaccocontrol.bmj.com
Background: Evidence-based smoking cessation guidelines recommend nicotine
replacement therapy (NRT), bupropion SR and varenicline as first-line therapy in …
replacement therapy (NRT), bupropion SR and varenicline as first-line therapy in …
[HTML][HTML] A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success
GF Prado, EMS Lombardi, MA Bussacos… - Clinics, 2011 - Elsevier
OBJECTIVE: To evaluate the effectiveness of nicotine replacement therapy (NRT),
bupropion, nortriptyline and combination therapy and describe factors associated with …
bupropion, nortriptyline and combination therapy and describe factors associated with …
A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials
JP Pierce, EA Gilpin - Nicotine & Tobacco Research, 2003 - JSTOR
Recently, a subcommittee of the Society for Research on Nicotine and Tobacco published
the group's recom mendations on measures of abstinence that should be reported for …
the group's recom mendations on measures of abstinence that should be reported for …
Pharmacotherapy for smoking cessation
L Carrozzi, F Pistelli, G Viegi - Therapeutic Advances in …, 2008 - journals.sagepub.com
Tobacco dependence is a chronic relapsing disease that needs continuous treatment. In
combination with behavioural support, pharmacotherapy is a proven key component for …
combination with behavioural support, pharmacotherapy is a proven key component for …
Current approaches to the management of smoking cessation
G Sutherland - Drugs, 2002 - Springer
Smoking remains a widespread intractable behaviour and is a significant cause of morbidity
and mortality worldwide. Effective approaches to smoking cessation include behavioural …
and mortality worldwide. Effective approaches to smoking cessation include behavioural …
Practical experiences in smoking reduction and cessation
CT Bolliger - Addiction, 2000 - Wiley Online Library
Tobacco use is a major cause of cardiovascular, respiratory and oncological disease.
Quitting smoking significantly benefits health, but for highly dependent smokers, unable to …
Quitting smoking significantly benefits health, but for highly dependent smokers, unable to …
An update on the pharmacotherapeutic interventions for smoking cessation
JL Barboza, R Patel, P Patel… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Cigarette smoking can damage every organ in the body and is the leading
known preventable cause of death globally. It is estimated that 70% of patients want to quit …
known preventable cause of death globally. It is estimated that 70% of patients want to quit …
Current issues in behavioral and pharmacological approaches to smoking cessation
P Hajek - Addictive behaviors, 1996 - Elsevier
Over the last 15 years or so, innovative research in behavioral treatments (BT) has given
way to research in nicotine replacement treatments (NRT), and there is a growing gap in …
way to research in nicotine replacement treatments (NRT), and there is a growing gap in …
Smoking cessation intervention: an evidence-based approach
R Laniado-Laborin - Postgraduate medicine, 2010 - Taylor & Francis
Cigarette smoking represents the most important source of preventable morbidity and
premature mortality worldwide. Approximately 100 million deaths were caused by tobacco …
premature mortality worldwide. Approximately 100 million deaths were caused by tobacco …
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
MJ Eisenberg, KB Filion, D Yavin, P Bélisle, S Mottillo… - Cmaj, 2008 - Can Med Assoc
Background: Many placebo-controlled trials have demonstrated the efficacy of individual
pharmacotherapies approved for smoking cessation. However, few direct or indirect …
pharmacotherapies approved for smoking cessation. However, few direct or indirect …